.
MergerLinks Header Logo

Announced

Completed

CONMED completed the acquisition of In2Bones Global for $255m.

Financials

Edit Data
Transaction Value£203m
Consideration TypeContingent Deferred Consideration, Cash
Capital Owned-
Capital Bid For100%
EV/Sales6.9x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

United States

Single Bidder

Domestic

Majority

Acquisition

Private

medical devices

Medical Equipment

Friendly

Completed

Synopsis

Edit

CONMED, a medical technology company, completed the acquisition of In2Bones Global, a global developer, manufacturer, and distributor of medical devices, for $255m. "This acquisition is a natural strategic extension of our Orthopedic portfolio. In2Bones is an exciting platform for CONMED to enter the extremities market given its broad portfolio, extensive sales channel, and experienced leadership team. We look forward to welcoming the In2Bones team to CONMED," Curt R. Hartman, CONMED Chair of the Board, President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US